PT Indofarma Tbk (ISX:INAF) Other Income (Expense) : Rp-8,481 Mil (TTM As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Other Income (Expense)?

PT Indofarma Tbk's other income expense for the PT Indofarma Tbk's pretax income for the three months ended in Sep. 2023 was Rp-4,640 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2023 was Rp-8,481 Mil.

PT Indofarma Tbk Other Income (Expense) Historical Data

The historical data trend for PT Indofarma Tbk's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Other Income (Expense) Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Income (Expense)

Get a 7-Day Free Trial

27,350.41

40,414.00

-10,270.51

-6,656.81

-18,865.68

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Income (Expense)	Get a 7-Day Free Trial															-6,588.14	-6,686.20	3,083.59	-238.50	-4,640.12

PT Indofarma Tbk Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-8,481 Mil.

PT Indofarma Tbk (ISX:INAF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines